NOVEL SPECIFIC MECHANISM FOR INHIBITION OF PLATELET ADHESION TO COLLAGEN Russian patent published in 2007 - IPC A61K38/17 A61P7/02 A61L29/16 A61M5/00 

Abstract RU 2302880 C2

FIELD: medicine.

SUBSTANCE: invention proposes using recombinant protein with the molecular mass 12 kDa from leech, Hirudo medicinalis, (saratin) that inhibits vWF-dependent formation of bond of platelets with artery wall collagen under condition of enhanced shift. Proposed agent is used for inhibiting platelets accumulation after vessel damage or endarterectomy for prevention of adhesion of platelets, thrombosis and restenosis. Also, invention proposes a coat for surface of surgery device or surgery tool based on thereof, hydrogel coat of catheter for administration and local delivery of saratin and using saratin as an agent for coat of surgery device or surgery tool, i. e. catheter, stent or intravascular transplant. Invention displays decreasing rate in thrombosis development and vessels occlusion in point of impact being in the absence of systemic effects as saratin doesn't influence on systemic bleeding and amount of platelets.

EFFECT: valuable medicinal properties of agent.

10 cl, 3 tbl, 9 dwg, 12 ex

Similar patents RU2302880C2

Title Year Author Number
PROTEIN CAPABLE ON INHIBITING COLLAGEN STIMULATED AGGREGATION OF THROMBOCYTES AND PREVENTING INTERACTION BETWEEN COLLAGEN AND vWF, METHOD OF PREPARING THEREOF, PHARMACOLOGICAL COMPOSITION BASED THEREON 1994
  • Jurgen Khemberger
  • Gvido Mel'Tser
RU2160280C2
POLYPEPTIDE WITH BIOLOGICAL ACTIVITY OF INHIBITOR OF COLLAGEN-INDUCED ADHESION OF PLATELETS, ITS PREPARING AND USING 2000
  • Shtrittmatter Vol'Fgang
  • Gjussov Detlef
  • Khofmann Uve
  • Khemberger Jurgen
  • Fotef Zizi
  • Shojble Bernkhard
RU2292351C2
THERAPEUTIC POLYPEPTIDES, HOMOLOGUES THEREOF, FRAGMENTS THEREOF AND APPLICATION THEREOF FOR MODULATION OF PLATELET-MEDIATED AGGREGATION 2004
  • Silans Karen
RU2524129C2
PREVENTION OF FORMATION AND/OR STABILISATION OF THROMBI 2005
  • Niesvandt Bernkhard
  • Rene Tomas
RU2514878C2
ISOLATED GLYCOPROTEIN IB ALPHA POLYPEPTIDE OF HUMAN THROMBOCYTES, FUSED PROTEIN, DNA MOLECULE (VERSIONS), EXPRESSION VECTOR (VERSIONS), CELL (VERSIONS), POLYPEPTIDE EXPRESSION METHOD, FUSED PROTEIN EXPRESSION METHOD, PHARMACEUTICAL COMPOSITION (VERSIONS), METHOD OF INHIBITING BODING OF BLOOD CELLS TO BIOLOGICAL TISSUE IN BIOLOGICAL SYSTEM, METHOD OF INHIBITING BONDING OF PROTEIN TO BIOLOGICAL TISSUE IN BIOLOGICAL SYSTEM AND DISORDER TREATMENT METHOD 2004
  • Sho Grej
  • Sako Dajann S.
  • Kumar Ravindra
  • Sjuj Tszin'
RU2403262C2
THERAPEUTIC APAC-MOLECULE CONTAINING HEPARIN CONJUGATED WITH BLOOD PLASMA PROTEIN 2015
  • Lassila Riitta
RU2714112C2
THERAPEUTICAL POLYPEPTIDES, THEIR HOMOLOGS, FRAGMENTS, AND APPLICATION IN THROMBOCYTE-MEDIATED AGGREGATION MODULATION 2004
  • Silans Karen
RU2357974C2
METHOD FOR PREVENTION OF SYSTEMIC PULMONARY BYPASS THROMBOSIS 2018
  • Diacovo, Thomas G.
RU2782074C2
VON WILLEBRAND FACTOR OR FACTOR VIII AND VON WILLEBRAND FACTOR FOR TREATMENT OF COAGULOPATHY, INDUCED BY PLATELET INHIBITORS 2009
  • Diknajte Gerkhard
  • Pragst Ingo
  • Lessa Ehnrike
  • Khaas Torsten
  • Tsajtler Shtefan
RU2563236C2
COLLAGEN-BASED INJECTIONS CAPABLE OF CONTROLLING HAEMORRHAGE AND/OR REPLACING PLATELET IN HAEMORRHAGIC SYNDROMES 2014
  • Vandru David
  • Dyumon Lora
  • De Mestr Emmanuel
RU2709738C1

RU 2 302 880 C2

Authors

Kristofer Barnes

Mattias Frekh

Uve Khofmann

Iogannes Glajtts

Vol'Fgang Shtrittmatter

Dates

2007-07-20Published

2001-08-23Filed